Amphastar Pharmaceuticals (AMPH) Gross Margin Growth (3y) (2016 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Gross Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 567.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -228.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -1,218.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 528.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 313.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 32,526.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -137.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 91.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 42.00 |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.00 |
| Mar 31, 2026 | -1,165.00 |
| Dec 31, 2025 | -592.00 |
| Sep 30, 2025 | 272.00 |
| Jun 30, 2025 | -173.00 |
| Mar 31, 2025 | 361.00 |
| Dec 31, 2024 | -6.00 |
| Sep 30, 2024 | 769.00 |
| Jun 30, 2024 | 558.00 |
| Mar 31, 2024 | 881.00 |
| Dec 31, 2023 | 1,558.00 |
| Sep 30, 2023 | 1,628.00 |
| Jun 30, 2023 | 1,125.00 |
| Mar 31, 2023 | 925.00 |
| Dec 31, 2022 | 1,267.00 |
| Sep 30, 2022 | 472.00 |
| Jun 30, 2022 | 1,034.00 |
| Mar 31, 2022 | 765.00 |
| Dec 31, 2021 | 784.00 |
| Sep 30, 2021 | 689.00 |